CMS: Relief from QIP Reporting

On March 22, 2020 CMS announced relief from QIP-related reporting requirements for CROWNWeb and the ESRD QIP.   Find the full CMS press release at https://www.cms.gov/newsroom/press-releases/cms-announces-relief-clinicians-providers-hospitals-and-facilities-participating-quality-reporting.  An excerpt follows:

“CMS will not count data from January 1, 2020 through June 30, 2020 (Q1-Q2) for performance or payment programs.  Data does not need to be submitted to CMS for this time period…  No data reflecting services provided January 1, 2020 through June 30, 2020 will be used in CMS’s calculations for the Medicare quality reporting… programs.  This is being done to reduce the data collection and reporting burden on providers responding to the COVID-19 pandemic.”

CMS published an additional bulletin on March 27, https://www.cms.gov/files/document/guidance-memo-exceptions-and-extensions-quality-reporting-and-value-based-purchasing-programs.pdf, with ESRD information on pp.9-10.  This bulletin clarifies the original and includes new information on NHSN QIP relief, and information on opting out of the relief:

“Dialysis facilities should be aware of the potential subsequent impact to a facility’s total performance score (TPS) when data are excluded from score calculations.  Facilities impacted by COVID-19 may elect to opt out of the CMS granted exception by emailing the request to the ESRD QIP at esrdqip@cms.hhs.gov.  The email must be sent by the dialysis facility’s chief executive officer (CEO) or designee.  We are requesting that a dialysis facility make this request within 90 days of March 22, 2020.  For further assistance regarding the ESRD QIP information contained in this message, please contact the ESRD QIP at esrdqip@cms.hhs.gov.”

Winter 2020 Patient Newsletters

We’ve published our Patient Newsletters for Winter 2020.  They feature articles on treatment options, flu shots, grievances, access to care, how to stay informed by the Network, and how to help the Network improve patient care.  Find them at:

AAKP/FDA Medical Device Survey

AAKP’s Center for Patient Research & Education (https://aakp.org/center-for-patient-research-and-education/research/) is collaborating with the FDA to foster engagement with patients, caregivers, and patient advocates throughout the development, evaluation and surveillance of medical devices in order to gain insight from patients and caregivers about their experiences living with their diseases as well as experiences with medical devices intended to diagnose and treat their medical conditions.  To further this effort, AAKP asks members to take a brief anonymous survey about the devices you have used.  Find the survey at https://www.surveymonkey.com/r/GGTZNKX.

7/15 NW18 Quality Conference 2019

Comagine Health ESRD Network 18 will hold its Annual Quality Conference 2019 in Los Angeles on July 15, 2019.  Topics include:

  • A Patient Panel Discussion on Patient Perspectives on Adherence to Treatment
  • New Changes to the ESRD QIP and How it Impacts Facilities
  • De-escalation of Disruptive Behaviors and the Social Work Role in Patient Advocacy
  • CROWNWeb Question and Answer
  • And More!

The program is designed for Facility Managers/Administrators, Nurses, Social Workers, Dietitians, Technicians, Medical Directors, and any other staff that would benefit from a great learning opportunity.  4.5 Nursing or Social Work CE credits are available.  For details and registration see http://events.r20.constantcontact.com/register/event?oeidk=a07egas42064eea495b&llr=gfuz7mxab&showPage=true.

SONG Glomerular Disease Survey

The Standardized Outcomes in Nephrology – Glomerular Disease (SONG-GD) study is an international initiative to identify outcomes in glomerular disease that are important to patients, caregivers, clinicians and other health professionals.  This will inform the development of core outcomes that are important and relevant to measure and report in glomerular disease.

SONG-GD includes a voluntary 15-minute survey to help determine a core outcome set for glomerulonephritis trials, to be taken by anyone who meets the following criteria:

  • You are 18 yrs of age or older
  • You are one of the following:
    • A patient with any major form of glomerular disease*, at any stage of development**
    • A family or household member of a patient with any major form of glomerular disease*, at any stage of development**
    • A caregiver for a patient with any major form of glomerular disease*, at any stage of development**
    • A healthcare practitioner or trainee, social worker, dietitian, pharmacist, psychologist, physiotherapist, researcher, policy-maker, or other stakeholder who deals with glomerular disease
    • You work in an industry that deals with glomerular disease
  • *Major forms of glomerular disease include:
      • ANCA vasculitis
      • Anti-GBM disease
      • Anti-glomerular basement membrane disease
      • Anti-neutrophil cytoplasmic antibody associated vasculitis
      • C3GN
      • Complement-mediated glomerulopathy
      • Focal segmental glomerulosclerosis
      • FSGS
      • Goodpasture’s disease
      • Goodpasture syndrome
      • GPS
      • Henoch-Schoenlein purpura
      • IgA nephropathy
      • IgA vasculitis
      • Lupus nephritis
      • Membranoproliferative glomerulonephritis
      • Membranous nephropathy
      • Minimal change disease
      • MPGN
  • **Stages of kidney disease development include:
      • Normal kidney function
      • Chronic kidney disease
      • ESRD, dialysis, or transplant

Answers will be completely anonymous and analyzed only in combination with other responses.  Find the survey at https://sydneypublichealth.au1.qualtrics.com/jfe/form/SV_djzDXYqzIQ0dMGN.  You will be asked for your name and email address so SONG-GD can send you a short follow-up survey.

4/5 DFC Technical Expert Panel Nominations

CMS has commissioned UM-KECC to assemble 10-20 volunteers for a Technical Expert Panel (TEP) to formulate a process for periodically resetting ESRD clinical quality Star-Rating criteria so that the Ratings continue to differentiate facility quality of care when treatment-quality trends reduce the variation between facilities.  Volunteers will include patients, caregivers, ESRD subject matter experts, methodologists, and specialists working on dialysis QI and healthcare disparities.  The TEP will require a one-day in-person meeting in Baltimore in June, plus 3-7 conference calls before and after.  Nominations must be submitted by April 5, 2019.  The current call for nominations doesn’t mention it, but past TEPs have reimbursed travel expenses.  For details and nomination forms, see https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/TEP-Currently-Accepting-Nominations.html#a0305.

NW16 2/15+ NWRD Conference, Portland

Northwest Renal Dietitians will hold their 2019 Annual Conference March 7-8, 2019 in Portland OR.  Topics include cardiac dysfunction, change motivation, diabetes management, and an evening networking event.  For details see https://docs.wixstatic.com/ugd/412302_a994fa9b56104e058440b04e5eeab527.pdf.

Find Conference details at https://www.nwrdonline.org/conference-overview.  Volunteers are welcome and appreciated.  NWRD includes renal dietitians from British Columbia, as well as the five Network 16 states.  There is no NWRD membership fee.